Roxanne Marshall

Glioma Groups Based on 1p/19q,<i>IDH</i>, and<i>TERT</i>Promoter Mutations in Tumors

Jeanette E. Eckel‐Passow, Daniel H. Lachance, Annette M Molinaro et al. · New England Journal of Medicine · 2015 · 2K citations · Full text

Medicine, Genetics, Molecular Genetics +17

Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance

Arman Jahangiri, Michael De Lay, Liane M. Miller et al. · Clinical Cancer Research · 2013 · 204 citations · Full text

Medicine, Oncology, Pharmacology +17

<i>CDKN2A</i>Loss Is Associated With Shortened Overall Survival in Lower-Grade (World Health Organization Grades II–III) Astrocytomas

Gerald F. Reis, Melike Pekmezci, Helen M. Hansen et al. · Journal of Neuropathology & Experimental Neurology · 2015 · 190 citations · Full text

Medicine, Oncology, Pathology +17

Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>

Tali Mazor, Charles Chesnelong, Aleksandr Pankov et al. · Proceedings of the National Academy of Sciences · 2017 · 140 citations · Full text

Medicine, Genetics, Oncology +15

The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas

Malak Abedalthagafi, Joanna J. Phillips, Grace Kim et al. · Modern Pathology · 2013 · 112 citations · Full text

Medicine, Genetics, Oncology +17